Related content

Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis

By Hasegawa Minoru   Fujimoto Manabu   Matsushita Takashi   Hamaguchi Yasuhito   Takehara Kazuhiko   Sato Shinichi  

Clinical Rheumatology, Vol. 30, Iss. 2, 2011-02 ,pp. : 231-237

Springer Publishing Company

Access to resources Recommend Favorite

Low‐dose intravenous cyclophosphamide in systemic sclerosis: an open prospective efficacy study in patients with early diffuse disease

By Valentini G.   Paone C.   La Montagna G.   Chiarolanza I.   Menegozzo M.   Colutta E.   Ruocco L.  

Scandinavian Journal of Rheumatology, Vol. 35, Iss. 1, 2006-02 ,pp. : 35-38

Informa Healthcare

Access to resources Recommend Favorite

The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis

By Ateş Aşkın   Kinikli Gülay   Turgay Murat   Duman Murat  

Clinical Rheumatology, Vol. 23, Iss. 5, 2004-10 ,pp. : 421-425

Springer Publishing Company

Access to resources Recommend Favorite

Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis

By Yanaba Koichi   Yoshizaki Ayumi   Asano Yoshihide   Kadono Takafumi   Sato Shinichi  

Clinical Rheumatology, Vol. 30, Iss. 6, 2011-06 ,pp. : 825-830

Springer Publishing Company

Access to resources Recommend Favorite

Escalation Therapy of Steroid Refractory Multiple Sclerosis Relapse with Tryptophan Immunoadsorption - Observational Multicenter Study with 147 Patients

By  

European Neurology, Vol. 75, Iss. 5-6, 2016-06 ,pp. : 300-306

Karger

Access to resources Recommend Favorite